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ABSTRACT 
Ether-a-go-go family (EAG) channels play a 
major role in many physiological processes in 
humans, including cardiac repolarization and cell 
proliferation. Cryo-EM structures of two of them, 
KV10.1 and human ether-a-go-go-related gene 
(hERG or KV11.1), have revealed an original non-
domain–swapped structure, suggesting that the 
mechanism of voltage-dependent gating of these 
two channels is quite different from the classical 
mechanical-lever model. Molecular aspects of 
hERG voltage-gating have been extensively 
studied, indicating that S4-S5 linker (S4-S5L) acts 
as a ligand binding to the S6 gate (S6 C-terminal 
part, S6T) and stabilizing it in a closed state. 
Moreover, the N-terminal extremity of the channel, 
called N-Cap, has been suggested to interact with 
S4-S5L to modulate channel voltage-dependent 
gating, as N-Cap deletion drastically accelerates 
hERG channel deactivation. In this study, using 
COS-7 cells, site-directed mutagenesis, 
electrophysiological measurements, and 
immunofluorescence confocal microscopy, we 
addressed whether these two major mechanisms of 
voltage-dependent gating are conserved in KV10.2 
channels. Using cysteine bridges and S4-S5L–
mimicking peptides, we show that the 
ligand/receptor model is conserved in KV10.2, 
suggesting that this model is a hallmark of EAG 
channels. Truncation of N-Cap domain, PAS 
domain, or both in KV10.2 abolished the current 
and altered channel trafficking to the membrane, 
unlike for the hERG channel in which N-Cap and 
PAS domain truncations mainly affected channel 
deactivation. Our results suggest that EAG 
channels function via a conserved ligand/receptor 
model of voltage gating, but that the N-Cap and 
PAS domains have different roles in these 
channels. 
 
 
Voltage-gated potassium (KV) channels 
regulate a variety of cellular processes, including 
membrane polarization (1,2), apoptosis (3), cell 
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proliferation (4), and cell volume (5). In 
connection with such a variety of functions of KV 
channels, mutations in these channels cause a 
variety of pathological conditions in humans: 
neurological disorders (6,7), cardiac arrhythmias 
(2), multiple sclerosis (8), pain syndrome (9). It 
has also been shown, that KV channels are 
associated with the development of malignant 
tumors cancer (10). KV10 channels belong to the 
ether-a-go-go family (EAG), as hERG channels. 
Two isoforms of KV10 channels are expressed in 
mammals: KV10.1 (eag1) and KV10.2 (eag2), 
which show 70% amino-acid sequence identity. 
KV10.1 has been detected mainly in the brain, 
while KV10.2 is also expressed in other tissues 
such as the skeletal muscles, the heart, the 
placenta, the lungs and the liver (11).  
Atomic structures of rat KV10.1 (12) and 
human hERG (KV11.1) channels (13) highlighted 
many structural similarities: non-swapped pore and 
voltage domains i.e. facing voltage-sensor and 
pore domains are from the same subunit, short S4-
S5 linkers (S4-S5L) and similar N-terminal 
structures such as PAS and N-Cap domains. We 
hypothesized that molecular mechanisms of gating 
identified in hERG may apply to the closely 
related KV10 channels.  
In the heart, deactivation of hERG channels 
(closing of the activation gate) is slow, allowing a 
major role for this channel in the late 
repolarization phase of the action potential. In this 
channel, two mechanisms have been shown to play 
a major role in the deactivation process.  
First, hERG deactivation is due to a voltage-
dependent interaction between the S4-S5 region, 
including the S4-S5 linker and a part of S5 (named 
S4-S5L, Figure 1A) and the C-terminal part of the 
S6 segment (named here S6T), which is the 
activation gate (14,15). In other words, at resting 
potentials, S4-S5L (the ligand) is bound to the S6T 
gate (the receptor) and locks it in a closed state (as 
shown in Figure 1B left). Upon membrane 
depolarization, S4 drags S4-S5L out of the S6T 
gate, and the channel opens (Figure 1B middle). 
Upon repolarization S4-S5L binds to the S6T gate 
and channel deactivates (back to Figure 1B left). 
Here, using two distinct approaches, we observe 
that this ligand/receptor mechanism, which we 
originally proposed for hERG, is conserved in 
KV10.2 (15).  
Second, hERG deactivation is modulated by 
the channel N-terminus. In the N-terminal eag 
domain, deletion in the N-Cap and/or the PAS 
domains, profoundly accelerated deactivation with 
no major effect on maximal current amplitude (16-
19). Moreover, covalent binding of the N-Cap and 
the S4-S5L closed the channel (20). These 
observations suggested that the N-Cap and/or the 
PAS domains regulate channel deactivation by 
modulating S4-S5L and S6T interaction. In KV10.2, 
we show that eag domain presents quite different 
functions. Deletions of the N-Cap and PAS 
domains, separately or altogether, completely 
abolish channel activity, at least partially due to a 
defect in membrane trafficking.  
In conclusion, we show that slowing 
activating channels follow an allosteric model, in 
which the voltage sensor and pore domains are 
weakly coupled, via a ligand, S4-S5L and a 
receptor, S6T. In KV10.2, such coupling is not 
modulated by the eag domain, as proposed for 
hERG (20). 
Results 
As in hERG, covalent binding of S4-S5L to S6T 
locks the KV10.2 channel closed 
The similar structures of hERG and KV10.1 
(12,13) showing a non-swapped arrangement of 
the pore and voltage sensor domains suggest that 
voltage-gating of these channels does not follow 
the classical mechanical-lever model in which S4-
S5L constricts the S6T gate (21). Also, functional 
evidence obtained by several groups including 
ours, strongly suggests that hERG channels do not 
follow the mechanical-lever model (14,15). First, 
Ferrer and collaborators, observed that 
introduction of a cysteine in S4-S5L (D540C) and 
another cysteine in S6T (L666C) locks the channel 
in a closed state in oxidative condition. This was 
associated to a restricted movement of the voltage 
sensor in oxidative condition, as measured by 
gating currents, suggesting the formation of a 
disulfide bridge (14). Also, mutagenesis 
experiments on hERG suggested electrostatic 
interaction between D540 and L666 playing a 
major role in hERG voltage dependent gating (22). 
Such observations suggest that in the WT hERG 
channel, specific interactions between S4-S5L and 
3 
 
the activation gate (S6T) stabilize the closed 
channel. In transfected COS-7 cells, we could 
reproduce the experiments originally done by 
Ferrer and collaborators in the Xenopus oocyte 
model (15). Moreover we could observe that a S4-
S5L mimicking peptide inhibits hERG channel, 
suggesting a ligand/receptor model, in which S4-
S5L, directly under the control of the voltage 
sensor S4, binds to S6T to lock the channel in a 
closed state (see Fig 1B, right). 
In order to check whether KV10.2 channels 
follow the same voltage-gating mechanism as 
hERG channels, we aligned the amino-acid 
sequences of the two channels, and mutated to a 
cysteine D339 and M474 in KV10.2, corresponding 
to hERG positions in which cysteines were 
previously introduced: D540 in S4-S5L and L666 
in S6T (14,15) (black arrows in Figure 1A). As for 
hERG double cysteine mutant, 2-hour application 
of 0.2 mM tbHO2 led to an almost complete 
inhibition of the D339C-M474C KV10.2 channel 
current (Figure 2A-B). Knowing the high 
homology between hERG and KV10.2 (65 %), we 
supposed that D339C and M474C in KV10.2 also 
form a disulfide bridge in oxidative condition, as a 
cause of the drastic current reduction. As control 
experiments, 0.2 mM tbHO2 application had no 
effect on tail current amplitude when only one 
(D339C or M474C KV10.2) or none (WT KV10.2) 
of the two cysteines was introduced (Figure 2C-H) 
and activation curves showed a similar shift in all 
conditions (Supplemental Figure 1). Since a 2-hour 
tbHO2 application represents a slow time course 
for a putative disulfide bridge formation, we also 
applied a higher concentration of tbHO2 (2 mM) 
for a shorter time. As in Ferrer study on hERG, 
this concentration led, in around 12 minutes, to an 
almost complete inhibition of the D339C-M474C 
KV10.2 channel current but not the WT channel 
current (Figure 3). This inhibition was reversed by 
10mM DTT, as in Ferrer study on hERG.  
To strengthen the hypothesis of the 
interaction between S4-S5L and S6T in KV10.2, we 
also tested tbHO2 effect on another double mutant 
of KV10.2 channel. We chose E343C-M474C 
KV10.2 channel, since E343, in S4-S5L, is aligned 
with E544 in hERG which, when mutated to a 
cysteine together with L666C in hERG S6T (Figure 
1A), also lead to channel inhibition, suggesting the 
formation of a disulfide bridge (15). We observed 
an inhibition of the current after 15’ incubation of 
2 mM tbHO2, which is reversed by 10 mM DTT 
(Figure 4A-B). Control experiments showed no 
effect either on tail current amplitude or on the 
activation curve when only one (E343C or M474C 
KV10.2) or none (WT KV10.2) of the two cysteines 
was introduced (Figure 4C-H; Supplemental 
Figure 2). Altogether, these observations 
confirmed that two different disulfide bridges 
created between the two introduced cysteines in 
S4-S5L and S6T locks KV10.2 in a closed state, as 
in hERG (14,15).  
As in hERG, a KV10.2 S4-S5L mimicking peptide 
inhibits KV10.2 channels 
 Recently, we observed that (i) co-
expressing a hERG S4-S5L mimicking peptide 
with hERG channel partially inhibited the 
generated current and (ii) covalently binding this 
peptide to the hERG channel completely inhibited 
it (15). These observations suggest that in hERG 
channels, S4-S5L rather acts as a voltage-
controlled ligand that binds to the S6T gate and 
stabilizes it in the closed state (Figure 1B left for 
the endogenous interaction and 1B right for the 
mimicking peptide). This mechanism of gating is 
consistent with Ferrer et al. observation that 
covalent binding of S4-S5L and S6T channel 
regions locks the channel in a closed state (14). 
Using the alignment between hERG and KV10.2 
(Figure 1A), we designed the KV10.2 S4-S5L 
peptide from the position of the S4-S5L peptide 
sequence that was inhibiting hERG channel (15). 
Co-expressing KV10.2 channel with its specific S4-
S5L peptide led to a profound decrease in current 
density (more than 70%), with no shift in the 
activation curve, as observed for hERG (Figure 
5A-E). As an additional control, co-expressing 
KV10.2 with a scramble S4-S5L peptide led to 
current density similar to the one observed in the 
absence of peptide (Figure 5A-B).  
Since the S4-S5L peptide is supposed to 
interfere with the gating, it may be intriguing that 
activating and tail currents are inhibited to the 
same extent, and that neither the activation curve, 
nor the activation kinetics are modified (Figure 
5C-F). To address this issue, we used a kinetic 
model mimicking the channel activity in 
presence/absence of the peptide (Figure 6), based 
on a previous model of KCNE1-KCNQ1 and S4-
S5L peptide interaction (23). In KCNE1-KCNQ1 
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model, the presence of the peptides was affecting 
the channel activation curve and activation 
kinetics. However, when constrained to KV10.2 
kinetics, the model did not show any alteration of 
activation kinetics or steady-state activation 
(Figure 6B-C). This is due to the fact that peptide 
binding and unbinding rates (0.02 and 0.04 s-1, 
respectively) are lower than channel 
opening/closing rates, because increasing these 
rates leads to alterations in channel activation 
kinetics and steady-state activation (Figure 6B-C). 
A peptide with similar binding/unbinding rates 
impact KCNE1-KCNQ1 channel activation curve 
and activation kinetics (23) because gating kinetics 
of this channel are slower than KV10.2 kinetics.  
Altogether, these observations support the 
ligand/receptor model of voltage dependence in 
KV10 channels.  
As opposed to hERG, N-Cap and PAS domains 
deleted KV10.2 channels are not functional  
The results described above suggest that in 
both KV10.2 and hERG channels, deactivation is 
due to S4-S5L binding to S6T and consequent 
stabilization of the closed state. It has been shown 
by several works that intracellular N-cap and PAS 
domains of hERG (shown in Figure 7A for 
KV10.2, cf. alignment in Supplemental Figure 3) 
modulate channel deactivation kinetics. Most 
importantly truncated hERG channel missing N-
Cap or the whole eag domain (N-Cap + PAS), 
when expressed in Xenopus oocytes, showed 
robust currents but a more than 5-fold acceleration 
in deactivation (16-19). Also in mammalian cells, 
it has been observed that eag domain is not 
necessary for hERG channel trafficking, consistent 
with the observation of robust currents in this 
model (24,25). Another work showed that N-Cap 
is close to S4-S5L (20). Thus, N-Cap may 
modulate channel deactivation through a direct 
interaction with this linker. Based on all these 
observations, we supposed that deletion of both N-
Cap and PAS domains in KV10.2 should give rise 
to functional channels with accelerated 
deactivation, as in the study on hERG in 
mammalian cells (25). Transfection of WT KV10.2 
tagged with 1D4 at the C-terminus gave rise to a 
current similar to previous description (6) and 
immunofluorescence experiments using this tag 
showed plasma membrane enrichment of the 
channel, compared to the intracellular 
compartment (Figure 7B-F). Surprisingly, deletion 
of N-Cap domain, PAS domain, but also of both 
domains all resulted in non-functional KV10.2 
channels (Figures 8B, 9B, 10B). 
Immunofluorescence experiments on N-Cap and/or 
PAS domains truncated channels showed no 
membrane enrichment of the channels (Figures 
8C-F, 9C-F, 10C-F). These findings suggest a 
trafficking defect of the N-Cap and/or PAS 
domains truncated Kv10.2 channels.  
As opposed to hERG, coexpressing a KV10.2 N-
Cap mimicking peptide with truncated KV10.2 
does not counteract the effect of channel 
truncation.  
For hERG channel, it has been shown that a 
peptide corresponding to the first 16 amino acids 
of the channel is sufficient to reconstitute slow 
deactivation to hERG lacking this region (Wang et 
al 2000). Similarly, another study has shown that 
injection of the purified eag domain, 
corresponding to the first 135 amino acids of 
hERG, into oocytes expressing eag-truncated 
hERG, restores the deactivation kinetics to wild-
type-like in more than 24 hours (Morais Cabral et 
al., 1998). Based on these previous observations on 
hERG, we proposed that co-expression of specific 
KV10.2 N-Cap mimicking peptides with the N-Cap 
truncated KV10.2 channel should recover its 
expression and activity at the plasma membrane. 
Surprisingly again, KV10.2 channel activity was 
not recovered in the presence of N-Cap mimicking 
peptide (n=8). This observation further suggests 
that N-Cap and PAS domains play distinct roles in 
hERG and KV10.2 function. 
Co-expression of WT and truncated KV10.2 
channels gives rise to a right shift in the 
activation curve as compared to homomeric WT 
channels, but no change in deactivation kinetics. 
 In order to evaluate the potential effects of 
N-Cap truncation on channel activity, we co-
expressed KV10.2 missing the N-Cap with the WT 
channel, in an attempt to generate heteromers. We 
observed robust voltage-dependent currents, 
showing a ~30-mV shift in the activation curve 
towards depolarized potential, demonstrating the 
generation of such heteromers (Figure 11C-F). 
This shift in the activation curve suggests that N-
Cap deletion leads not only to a KV10.2 trafficking 
defect but also to a gating defect. In hERG 
channel, deletion of N-Cap did not lead to a shift 
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of the activation curve, but an acceleration of 
deactivation (26). In the present experiments on 
KV10.2, no change in deactivation kinetics was 
observed when the N-Cap truncated channel was 
co-expressed with the WT channel (Figure 12). We 
also co-expressed the KV10.2 channel construct 
lacking both the N-Cap and PAS domains, with the 
WT channel. Again, we observed a ~30-mV shift 
in the activation curve towards depolarized 
potentials, but no modification in deactivation 
(Figures 11 & 12). Thus, although we are likely 
recording the combined activities of tetrameric 
channels containing different ratios of the WT and 
truncated subunits, it appears that N-terminal 
deletion of KV10.2 impacts the steady-state 
activation curve rather than deactivation kinetics.  
Discussion 
From the present work and previous works, 
we suggest that among voltage-gated channels, 
coupling between voltage sensor movement and 
pore gating falls into two categories: (i) the 
mechanical-lever model: an obligatory coupling in 
which S4 resting state directly translates into S6 
gate closed state. This mechanical-lever model, 
inferred from structural data in Shaker-like 
channels (27), also applies to eukaryotic sodium 
channels, as suggested by recent structural studies 
(28,29); (ii) the ligand/receptor model: the 
obligatory coupling cannot hold if the S6T gate is 
able to open, even if S4 segments are in the resting 
state, as shown for hERG and KCNQ1 channels 
(30-32), and, vice-versa, if S6T gate is able to 
close, even if S4 segments are in the activated state 
(33). We recently demonstrated this 
ligand/receptor model in hERG channels by using 
several approaches. Here, were obtained similar 
results on KV10.2 using similar approaches.  
First, introduction of cysteines in S4-S5L 
and S6T, lock the channel in a closed state in 
oxidative condition, suggesting the formation of a 
disulfide bridge, as in hERG. This suggests that the 
same gating mechanism applies to KV10.2. 
Introduction of cysteines in both S4-S5L and S6T 
may lead to a non-native conformation that favor 
an S4-S5L interaction with S6T, which would not 
be met in WT channel. But in the second set of 
experiments, a S4-S5L mimicking peptide, without 
any introduced cysteine, inhibits KV10.2 channel, 
also without any introduced cysteine, further 
suggesting the capability of S4-S5L to stabilize the 
channel closed state. Noteworthy, similar channel 
specific peptides have the same effect in KCNQ1 
and hERG channels (15,23). Complementary 
experiments in hERG revealed that S4-S5L peptide 
effects was on channel gating, and not channel 
trafficking (15).  
Altogether these experiments suggest that 
KV10.2 follows the ligand/receptor mechanism 
observed in hERG. In both channels, S4-S5 linkers 
are short (12,13), thus it is likely that the part of S5 
which is present in the peptide also plays a role in 
closed channel stabilization. Further structural data 
of hERG and KV10.2 channels in the closed state 
should clarify the residues involved in the S4-S5L 
and S6T interaction. Noteworthy, this 
ligand/receptor model is consistent with the 
observation that the voltage-dependent closure of 
the related KV10.1 channel, but also of the hERG 
channel, requires at least a part of the inhibiting 
S4-S5L to be covalently linked to the voltage 
sensor S4 (34,35).   
As opposed to similar ligand/receptor gating 
mechanisms in the two channels, the role of the 
eag domain (N-Cap + PAS) is quite different 
between hERG and KV10.2. In hERG channels, the 
eag domain (N-Cap + PAS) is not necessary for 
channel activity and mainly modulates the current 
deactivation rate (17-19). Here, we observed that 
truncation of KV10.2 eag domain renders the 
channel nonfunctional, at least partly due to 
trafficking defects. In rescue experiments with the 
WT channel, we observed that eag domain deletion 
or even only N-Cap deletion are associated with a 
shift in the activation curve, but no change in 
channel deactivation. The contrary is observed in 
hERG channel: an altered deactivation, no shift in 
the activation curve (26,36). Our results suggest 
major differences in functional roles for the N-Cap 
and PAS domains between KV10.2 and hERG. 
Altogether, this work suggests a conserved 
ligand/receptor (allosteric) model of voltage 
gating, but divergent roles in eag domains among 
channels of the EAG family.  
In combination with a previous work on 
hERG, this study highlights in the voltage-gated 
channels superfamily, divergent gating 
mechanisms (obligatory vs. allosteric) that matches 
divergent structure (swapped vs non-swapped 
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domain, respectively) and divergent kinetics (fast 
vs. slow activating channels, respectively). Non-
swapped domains (hERG, KV10) may provide less 
contact between S4-S5L and S6T (12,13). We 
propose that this weak coupling between S4-S5L 
and S6T provides a framework for a two-step 
channel activation: first, the fast S4 movement 
drags the ligand S4-S5L out of its receptor on the 
S6T gate, followed by slow gate opening. This 
allosteric regulation of the S6T gate by S4-S5L may 
explain how in slowly activating channels, 
movement of S4 is not concomitant to pore 
opening (37). 
Experimental procedures 
Plasmid constructs. pCDNA6 hKV10.2 was 
subcloned into pMT3 vector using the standard 
PCR overlap extension method (38). A 1D4 
immunoaffinity tag (derived from the C-terminus 
of bovine rhodopsin) was added to the C-terminus 
of all constructs (39). The D339C, E343C, 
M474C, E343C-M474C and D339C-M474C 
mutations were inserted into the pMT3-KV10.2 
construct using the QuikchangeTM site directed 
mutagenesis-based techniques using Accuprime 
Pfx polymerase (ThermoFisher Scientific) 
according to the standard protocol recommended 
by the manufacturer. Truncation mutants were 
constructed by deleting residues 2 to 24 (ΔN-
CAP), 2 to 134 (Δeag) and 25 to 134 (ΔPAS) using 
the standard PCR overlap extension method. PCR 
products were digested with HindIII and XbaI and 
ligated into pCDNA6 and PMT3 vectors. All 
constructs were confirmed by sequencing. 
Oligonucleotides encoding KV10.2 peptides were 
synthesized by TOP Gene Technologies and 
contained a XhoI restriction enzyme, followed by a 
methionine (ATG) for translation initiation, a 
glycine (GGA) to protect the ribosome binding site 
during translation and the nascent peptide against 
proteolytic degradation (40). A BamHI restriction 
enzyme site was synthesized at the 3′ end 
immediately following the translational stop codon 
(TGA). These oligonucleotides were then ligated 
into pIRES2-EGFP (Clontech) and sequenced.  
 
Cell culture and transfection. The African 
green monkey kidney-derived cell line COS-7 was 
obtained from the American Type Culture 
Collection (CRL-1651) and cultured in Dulbecco’s 
modified Eagle’s medium (GIBCO) supplemented 
with 10% fetal calf serum and antibiotics (100 
IU/ml penicillin and 100 µg/ml streptomycin) at 
5% CO2 and 95% air, maintained at 37°C in a 
humidified incubator. Cells were transfected in 35-
mm Petri dishes when the culture reached 50-60% 
confluence, with 4 µg total DNA complexed with 
12 µl Fugene-6 (Roche Molecular Biochemical) 
according to the standard protocol recommended 
by the manufacturer. In the different experiments, 
plasmid quantities were optimized to keep current 
amplitudes in such a range, that undetectable 
currents were rare, and large currents inducing 
incorrect voltage-clamp were also rare. 
Immunofluorescence and confocal microscopy 
experiments were done with pCDNA6-KV10.2 for 
which channel expression was lower than with 
pMT3-KV10.2, to limit intracellular accumulation 
of the protein. For disulfide bridge experiments, 
COS-7 cells were co-transfected with 3.6 µg 
pMT3-WT or D339C-M474C or E343C-M474C 
or D339C or E343C or M474C KV10.2 and 0.4 µg 
pEGFP. For S4-S5L peptide experiments, COS-7 
cells were co-transfected with 2 µg pMT3-WT 
KV10.2 and 2 µg pIRES2-EGFP plasmids 
encoding or not the S4-S5L peptide. As an 
additional control, a pIRES2-EGFP plasmid 
encoding a scramble S4-S5L peptide was used. In 
pIRES2-EGFP plasmids, the second cassette 
(EGFP) is less expressed than the first cassette, 
guaranteeing high levels of peptides expression in 
fluorescent cells (23). For N-terminal deletion 
experiments, COS-7 cells were co-transfected with 
2 µg pCDNA6-N-Cap truncated KV10.2 and 2µg 
pIRES2-EGFP plasmids encoding or not the N-
Cap mimicking peptide. For immunofluorescence 
and confocal microscopy experiments, COS-7 cells 
were transfected with 4 µg pCDNA6-
WT/truncated KV10.2. For WT/truncated 
heteromeric KV10.2 experiments, COS-7 cells 
were co-transfected with 1.8 µg pMT3-WT 
KV10.2, 1.8 µg pMT3-truncated KV10.2 and 0.4 µg 
pEGFP. Cells were re-plated onto 35-mm Petri 
dishes the day after transfection for patch-clamp 
experiments. 
Electrophysiology. One day after splitting, 
COS-7 cells were mounted on the stage of an 
inverted microscope and constantly perfused by a 
Tyrode solution (cf. below) at a rate of 1-3 ml/min. 
The bath temperature was maintained at 22.0 ± 
2.0°C. Stimulation and data recording were 
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performed with Axon pClamp 10, an A/D 
converter (Digidata 1440A) and an Axopatch 200B 
amplifier (all Molecular Devices). Patch pipettes 
(tip resistance: 2–3 MOhms) were pulled from 
soda lime glass capillaries (Kimble-Chase) and 
coated with wax. Currents were recorded in the 
whole-cell configuration, pipette capacitance and 
series resistance were electronically compensated 
(by around 75%). Activation protocols were 
adjusted to the voltage-dependence of the construct 
as in the previous study on hERG (15). Activation 
curves were obtained from the tail currents and 
fitted by Boltzmann equations.  
 
Confocal Microscopy. Immunohistological 
analyses were performed to study cell localization 
of transfected WT/truncated KV10.2-1D4 in COS-
7 cells. Twenty-four hours after transfection, cells 
were plated on IBIDI plates for 24 h. Cells were 
then fixed with 4% formaldehyde, stained for 10 
minutes at room temperature with Alexa Fluor™ 
647 Conjugated Wheat Germ Agglutinin (WGA; 
ThermoFisher), a plasma membrane marker, 
permeabilized with 0.5% saponin and blocked with 
1% PBS-BSA. Cells were then incubated with a 
mouse monoclonal antibody directed against the 
1D4 tag diluted in PBS (Abcam). Secondary 
antibody staining was performed using Alexa 488-
conjugated anti-mouse antibody. DAPI was used 
for nuclear staining. Conventional imaging was 
performed using a LSM710-Confocor3 (Zeiss) and 
a Nikon Confocal A1RSi microscope system 
equipped with a SR Apo 100 × 1.49 N.A objective. 
Images were analyzed with Image J software. In 
figures, but not for analyses, Enhance Local 
Contrast adjustment was performed on WGA 
staining to highlight plasma membrane staining.  
To quantify fluorescence, the line plot was 
arbitrarily segmented in 3 different regions: the 
first and last 5-15% of the line plot, corresponding 
to plasma membrane (M1 and M2), and the 
remaining intermediate 70% of the line plot, 
corresponding to the intracellular compartment. 
For each of these regions in each cell, KV10.2 
fluorescence intensity values were normalized by 
the average cell KV10.2 fluorescence intensity 
signal (41). 
 
Solutions. Cells were continuously 
superfused with a HEPES-buffered Tyrode 
solution containing (in mmol/L): NaCl 145, KCl 4, 
MgCl2 1, CaCl2 1, HEPES 5, glucose 5, pH 
adjusted to 7.4 with NaOH. Patch pipettes were 
filled with the following solution (in mmol/L): 
KCl 100, K-gluconate 45, MgCl2 1, EGTA 5, 
HEPES 10, pH adjusted to 7.2 with KOH. For 
experiments in Figure 3, 1mM K2ATP was added 
to limit current rundown. The membrane-
permeable oxidizing agent tert-butylhydroperoxide 
(tbHO2) was obtained from Sigma. Incubation of 
COS-7 cells with 0.2mM or 2mM tbHO2 was 
realized at room temperature. 
 
Kinetic model. The KV10.2 kinetic model 
(Figure 6A top) contains two voltage sensor 
transitions, and two open states, as in the model of 
IKs (42). This model was optimized using 
IChMASCOT (J.A. De Santiago-Castillo and M. 
Covarrubias) to fit traces of the representative 
control of Figure 5. Optimized transition rates are 
presented in Table 1. Next, another model was 
designed (Figure 6A bottom), with an additional 
state in which S4-S5L mimicking peptide binds to 
the pre-open state and stabilizes it, as in (23). 
Various S4-S5L binding/unbinding transition rates 
were applied, and the effects on the biophysical 
parameters were studied. 
Statistics. All data are expressed as means ± 
sem. Statistical differences between current 
densities (data points are not normally distributed) 
were determined using non parametric Mann 
Whitney test. Statistical differences between 
activation parameters, V0.5, K (data points are 
normally distributed) were determined using 
unpaired Student’s t-tests. A value of p < 0.05 was 
considered significant.  
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Table 1 
Transition description  Transition rate (s-1) 
Voltage sensor transition rates 
Closed Locked 2 (CL2)            
Closed Locked 1 (CL1) 
 








TR
FV
14.0exp50.8  
CL1 CL2  







TR
FV
10.0exp35.13  
CL1  Closed unlock (CU)  







TR
FV
42.0exp95.15  
CU  CL1  







 
TR
FV
76.0exp1012.4 2  
Concerted opening transition rates 
4 monomers CU or CUP6  Open 
state 1 (O1) 
 








TR
FV
36.0exp7.260  
O1  4 monomers CU or CUP6  







TR
FV
61.0exp66.64  
O1  Open state 2 (O2)  






 
TR
FV
37.2exp1020.6 3  
O2  O1  








TR
FV
46.2exp74.12  
F = 96485 C.mol-1 (Faraday constant); R = 8.314 J.mol-1.K-1 (Gas constant); T = 297 K; V (membrane 
potential) in V 
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Figure 1: Alignment used to design the cysteine mutants and the S4-S5L peptide - hypothetical 
ligand/receptor model. A: alignment between hERG and KV10.2. This alignment was used to (i) 
introduce the cysteines in S4-S5L and S6T and (ii) design the S4-S5L peptide from the previously identified 
hERG S4-S5L inhibiting peptide. S4-S5L refers to the S4-S5 region, including the S4-S5 linker and a 
part of S5. S6T refers to the C-terminal part of the S6 segment, which is the activation gate. The 
alignment was obtained using Cobalt (43). In red are represented the basic residues, in yellow acidic 
residues, and in purple the position of the narrowest part of the bundle crossing, also named the gating 
residue (44). The color boxes represent the transmembrane segments. Introduced cysteines in hERG (15) 
and in KV10.2 in the present study are indicated. Grey line represents the inhibiting S4-S5L peptide in 
hERG (15). Red line represents the peptide engineered in KV10.2 for the present study. B. Left: scheme of 
the hypothetical ligand/receptor model in which S4-S5L (deep blue) binds to S6T (light blue) to stabilize 
the channel in a closed state. Middle: upon membrane depolarization, S4 pulls S4-S5L out of the S6T 
receptor, allowing channel opening. Right: the KV10.2 S4-S5L peptide (red) mimics endogenous S4-S5L, 
locking the channel in its closed conformation.  
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Figure 2: introduction of 2 cysteines in the S4-S5L and S6T regions of KV10.2 (D339C-M474C 
KV10.2) locks the channel closed in oxidative conditions. A: representative, superimposed recordings of 
the D339C-M474C KV10.2 current after 2h incubation in Tyrode without (control) or with 0.2 mM tbHO2 
(tbHO2). Left inset: activation voltage protocol used (one sweep every 8 s). Right inset: scheme of S4-
S5L/S6T with introduced cysteines (stars) B: mean ± sem D339C-M474C KV10.2 maximum tail-current 
density, in control or tbHO2. ***p<0.001 versus control, Mann-Whitney test. C & D: same as A & B for 
WT KV10.2. E & F: same as A & B for D339C KV10.2. G & H: same as A & B for M474C KV10.2.
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Figure 3: kinetics of D339C-M474C KV10.2 current reduction upon addition of 2 mM tbHO2. Time 
course of the effect of tbHO2 application on normalized WT and D339C-M474C KV10.2 tail currents. 
From a holding potential of -100mV, followed by a 3-s prepulse at -40 mV, tail currents were recorded at 
+80 mV, every 8 s. Following stabilization of the tail current, 2 mM tbHO2 was perfused (grey arrow), 
and the step protocol was repeated for 6 min. Following the tbHO2 application, a fraction of the cells was 
then perfused with 10 mM DTT, and the step protocol was continued for an additional 6 min. Each data 
point represents the mean ± sem current magnitude normalized to values obtained before tbHO2. n = 16 
(WT), 19 (D339C–M474C in tbHO2), and 7 (D339C–M474C in DTT). Insets (a,b,c,d) corresponds to 
representative recordings at the arrows.  
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Figure 4: introduction of 2 cysteines in the S4-S5L and S6T regions of KV10.2 (E343C-M474C 
KV10.2) locks the channel closed in oxidative conditions. A: representative, superimposed recordings of 
the E343C-M474C KV10.2 current after 15 min incubation in Tyrode without (control) or with 2 mM 
tbHO2 (tbHO2), or after subsequent 5 min incubation in 10 mM DTT (DTT). Left inset: activation voltage 
protocol used (one sweep every 8 s). Middle and right insets: Schemes of S4-S5L/S6T with introduced 
cysteines in presence of tbHO2 or DTT, respectively (stars). B: mean ± sem E343C-M474C KV10.2 
maximum tail-current density, in control, tbHO2, or tbHO2 followed by DTT. ***p<0.001, Mann-Whitney 
test. C & D: same as A & B for WT KV10.2. E & F: same as A & B for E343C KV10.2. G & H: same as 
A & B for M474C KV10.2.  
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Figure 5: S4-S5L
 
peptide inhibits KV10.2 channels. A: representative, superimposed recordings of the 
WT KV10.2 current in the absence (left; 2 µg KV10.2 plus 2 µg GFP encoding plasmids), in the presence 
of S4-S5L peptide (middle; 2 µg KV10.2 plus 2 µg peptide encoding plasmids) and in the presence of a 
scramble S4-S5L peptide (right; 2 µg KV10.2 plus 2 µg peptide encoding plasmids).  Left insets: schemes 
of the hypothetical effect of the S4-S5L
 
inhibiting peptide on KV10.2 channel; Right inset: activation 
voltage protocol used (one sweep every 8 s). B: mean ± sem KV10.2 maximum tail-current density in the 
absence or presence of the indicated peptide (S4-S5L peptide or scramble S4-S5L peptide). ***p<0.001, 
Mann-Whitney test. C: activation curve, obtained from tail currents using the protocol shown in A, in the 
absence or the presence of the indicated peptide. (n=16-25). D: mean ± sem half-activation potential in the 
absence or the presence of the indicated peptide. E: mean ± sem activation curve slope in the absence or 
the presence of the indicated peptide. F: mean ± sem half-activation time as a function of membrane 
potential, in the absence or the presence of the indicated peptide.  
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Figure 6: kinetic model of KV10.2 and its interaction with the S4-S5L peptide. A: kinetic model 
schemes. This model is based on a previous work on KCNE1-KCNQ1 (23). a: kinetic model in the 
absence of peptide, on which optimization has been performed (see experimental procedures). Optimized 
transition rates are presented in Table 1. b: binding of exogenous S4-S5L locks the channel and prevents 
its opening. Peptides are supposed to interact with each monomer in the unlocked states. B: simulated 
currents during step protocols (same as in figure 5), in the absence (Ctrl) or the presence of S4-S5L 
peptide, at the indicated S4-S5L on/off rates. C: Grey filled circles: experimental activation curves and 
half-activation times in control condition. Other symbols: simulated values in the absence of peptide 
(control, open circles), or in the presence of peptides, at the indicated rates of peptide binding/unbinding. 
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Figure 7: WT KV10.2 characterization in transfected COS-7 cells. A: domains organization of the 
channel, showing the eag domain (N-Cap + PAS), a linker domain (L, also named proximal N-
terminus), the voltage sensing domain (VSD), the pore domain, C-linker, CNBHD, and C-tail. B: 
representative, superimposed recordings of the WT KV10.2-1D4 current. Inset: voltage protocol used (one 
sweep every 8 s). C: representative confocal immunostainings of WT KV10.2-1D4 in transfected COS-7 
cells (in green). WGA (wheat germ agglutinin) is used as a membrane marker (in red). Nuclei are stained 
with DAPI (in blue). Scale = 15 μm. D: mean ± sem fluorescence of KV10.2 signal in plasma membrane 
(M1 and M2) and cytosol, as measured in E and F, normalized by the average KV10.2 fluorescence. 
*p<0.05 versus cytosol, paired Student’s t-test. E & F. Left: expanded view of two selected cells, showing 
the Golgi (stars) and the line used for the line plots shown in right. Lines have been placed as far as 
possible from the Golgi to generate accurate plasma membrane plots. Right: line plots of WGA (red) and 
KV10.2 (green) at the level of the drawn lines in left. Higher KV10.2 fluorescence densities are observed in 
the region of the plasma membrane.  
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Figure 8: ΔN-Cap KV10.2 characterization in transfected COS-7 cells. A: domains organization of the 
channel, showing the N-Cap deletion. B: representative, superimposed recordings of the ΔN-Cap KV10.2-
1D4 current. Inset: voltage protocol used (one sweep every 8 s). C: representative confocal 
immunostainings of ΔN-Cap KV10.2-1D4 in transfected COS-7 cells (in green). WGA (wheat germ 
agglutinin) is used as a membrane marker (in red). Nuclei are stained with DAPI (in blue). Scale = 15 μm. 
D: mean ± sem fluorescence of KV10.2 signal in plasma membrane (M1 and M2) and cytosol, as 
measured in E and F, normalized by the average KV10.2 fluorescence. E & F. Left: expanded view of two 
selected cells, showing the Golgi (stars) and the line used for the line plots shown in right. Lines have 
been placed as far as possible from the Golgi to generate accurate plasma membrane plots. Right: line 
plots of WGA (red) and KV10.2 (green) at the level of the drawn lines in left. Higher KV10.2 fluorescence 
densities are not observed in the region of the plasma membrane, as opposed to the WT condition. 
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Figure 9: Δeag KV10.2 characterization in transfected COS-7 cells. A: domains organization of the 
channel, showing the eag domain deletion. B: representative, superimposed recordings of the Δeag 
KV10.2-1D4 current. Inset: voltage protocol used (one sweep every 8 s). C: Representative confocal 
immunostainings of Δeag KV10.2-1D4 in transfected COS-7 cells (in green). WGA (wheat germ 
agglutinin) is used as a membrane marker (in red). Nuclei are stained with DAPI (in blue). Scale = 15 μm. 
D: mean ± sem fluorescence of KV10.2 signal in plasma membrane (M1 and M2) and cytosol, as 
measured in E and F, normalized by the average KV10.2 fluorescence. E & F. Left: expanded view of two 
selected cells, showing the Golgi (stars) and the line used for the line plots shown in right. Lines have 
been placed as far as possible from the Golgi to generate accurate plasma membrane plots. Right: line 
plots of WGA (red) and KV10.2 (green) at the level of the drawn lines in left. Higher KV10.2 fluorescence 
densities are not observed in the region of the plasma membrane, as opposed to the WT condition. 
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Figure 10: ΔPAS KV10.2 characterization in transfected COS-7 cells. A: domains organization of the 
channel, showing the PAS domain deletion. B: representative, superimposed recordings of the ΔPAS 
KV10.2-1D4 current. Inset: voltage protocol used (one sweep every 8 s). C: Representative confocal 
immunostainings of ΔPAS KV10.2-1D4 in transfected COS-7 cells (in green). WGA (wheat germ 
agglutinin) is used as a membrane marker (in red). Nuclei are stained with DAPI (in blue). Scale = 15 μm. 
D: mean ± sem fluorescence of KV10.2 signal in plasma membrane (M1 and M2) and cytosol, as 
measured in E and F, normalized by the average KV10.2 fluorescence. E & F. Left: expanded view of two 
selected cells, showing the Golgi (stars) and the line used for the line plots shown in right. Lines have 
been placed as far as possible from the Golgi to generate accurate plasma membrane plots. Right: line 
plots of WGA (red) and KV10.2 (green) at the level of the drawn lines in left. Higher KV10.2 fluorescence 
densities are not observed in the region of the plasma membrane, as opposed to the WT condition. 
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Figure 11: co-expression of WT and truncated KV10.2 channels uncovers a right shift in the 
activation curve, as compared to WT channel. A: domain organization of WT and truncated channels. 
B: representative, superimposed recordings of COS-7 cells transfected with WT KV10.2 channel (left), 
WT and ΔN-Cap KV10.2 (middle) and WT and Δeag KV10.2 (right). Inset: activation voltage protocol 
used (one sweep every 8 s). C: mean ± sem KV10.2 maximum tail-current density, in the indicated 
conditions. *p<0.05 versus WT, Mann-Whitney test. D: activation curve in the indicated conditions. E: 
mean ± sem half-activation potential (V0.5). ***p<0.001 versus WT, Student’s t-test.  F: mean ± sem 
activation slope (k). ***p<0.001 versus WT, Student’s t-test.  
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Figure 12: co-expression of WT and truncated KV10.2 channels is not associated with changes in 
deactivation kinetics, as compared to WT channel. A: representative, superimposed recordings of 
COS-7 cells  transfected with WT KV10.2 channel (left), WT and ΔN-Cap KV10.2 (middle),  and WT and 
Δeag KV10.2 (right). Upper inset: deactivation tail voltage protocol used (prepulse duration 3s, one sweep 
every 7 s). B: mean ± sem KV10.2 deactivation time constant, obtained from a mono-exponential fit of the 
deactivating current. 
 
